Cargando…
Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()()
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510340/ https://www.ncbi.nlm.nih.gov/pubmed/32949593 http://dx.doi.org/10.1016/j.metabol.2020.154374 |
| _version_ | 1783585765734744064 |
|---|---|
| author | Moin, Abu Saleh Md Sathyapalan, Thozhukat Atkin, Stephen L. Butler, Alexandra E. |
| author_facet | Moin, Abu Saleh Md Sathyapalan, Thozhukat Atkin, Stephen L. Butler, Alexandra E. |
| author_sort | Moin, Abu Saleh Md |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7510340 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75103402020-09-24 Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()() Moin, Abu Saleh Md Sathyapalan, Thozhukat Atkin, Stephen L. Butler, Alexandra E. Metabolism COVID-19 in Metabolism Elsevier Inc. 2020-11 2020-09-16 /pmc/articles/PMC7510340/ /pubmed/32949593 http://dx.doi.org/10.1016/j.metabol.2020.154374 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | COVID-19 in Metabolism Moin, Abu Saleh Md Sathyapalan, Thozhukat Atkin, Stephen L. Butler, Alexandra E. Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()() |
| title | Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()() |
| title_full | Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()() |
| title_fullStr | Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()() |
| title_full_unstemmed | Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()() |
| title_short | Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()() |
| title_sort | pro-fibrotic m2 macrophage markers may increase the risk for covid19 in type 2 diabetes with obesity()() |
| topic | COVID-19 in Metabolism |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510340/ https://www.ncbi.nlm.nih.gov/pubmed/32949593 http://dx.doi.org/10.1016/j.metabol.2020.154374 |
| work_keys_str_mv | AT moinabusalehmd profibroticm2macrophagemarkersmayincreasetheriskforcovid19intype2diabeteswithobesity AT sathyapalanthozhukat profibroticm2macrophagemarkersmayincreasetheriskforcovid19intype2diabeteswithobesity AT atkinstephenl profibroticm2macrophagemarkersmayincreasetheriskforcovid19intype2diabeteswithobesity AT butleralexandrae profibroticm2macrophagemarkersmayincreasetheriskforcovid19intype2diabeteswithobesity |